Fu, D., Li, C., & Huang, Y. (2021). Lipid–Polymer Hybrid Nanoparticle-Based Combination Treatment with Cisplatin and EGFR/HER2 Receptor-Targeting Afatinib to Enhance the Treatment of Nasopharyngeal Carcinoma. Onco Targets Ther.
Chicago Stili AlıntıFu, Dehui, Chao Li, ve Yongwang Huang. "Lipid–Polymer Hybrid Nanoparticle-Based Combination Treatment With Cisplatin and EGFR/HER2 Receptor-Targeting Afatinib to Enhance the Treatment of Nasopharyngeal Carcinoma." Onco Targets Ther 2021.
MLA AlıntıFu, Dehui, Chao Li, ve Yongwang Huang. "Lipid–Polymer Hybrid Nanoparticle-Based Combination Treatment With Cisplatin and EGFR/HER2 Receptor-Targeting Afatinib to Enhance the Treatment of Nasopharyngeal Carcinoma." Onco Targets Ther 2021.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..